Atlas Trials

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

Clinical trial NCT03441789 · COMPLETED

Trial details

NCT number
NCT03441789
Sponsor
L.H. Kircik, M.D.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2017-09-18
Primary completion
2018-10-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.